1. Home
  2. CTRA vs GMAB Comparison

CTRA vs GMAB Comparison

Compare CTRA & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coterra Energy Inc.

CTRA

Coterra Energy Inc.

HOLD

Current Price

$25.49

Market Cap

19.6B

Sector

Energy

ML Signal

HOLD

Logo Genmab A/S ADS

GMAB

Genmab A/S ADS

HOLD

Current Price

$33.66

Market Cap

20.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRA
GMAB
Founded
1989
1999
Country
United States
Denmark
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.6B
20.4B
IPO Year
1990
N/A

Fundamental Metrics

Financial Performance
Metric
CTRA
GMAB
Price
$25.49
$33.66
Analyst Decision
Buy
Strong Buy
Analyst Count
16
6
Target Price
$32.81
$40.40
AVG Volume (30 Days)
6.9M
1.6M
Earning Date
02-23-2026
02-11-2026
Dividend Yield
3.48%
N/A
EPS Growth
31.20
132.41
EPS
2.17
25.10
Revenue
$6,666,000,000.00
$3,845,670,022.00
Revenue This Year
$47.54
$24.85
Revenue Next Year
$5.27
$16.51
P/E Ratio
$11.67
$1.35
Revenue Growth
25.92
29.57
52 Week Low
$22.33
$17.24
52 Week High
$29.95
$33.99

Technical Indicators

Market Signals
Indicator
CTRA
GMAB
Relative Strength Index (RSI) 45.42 60.57
Support Level $24.74 $30.35
Resistance Level $26.70 $33.96
Average True Range (ATR) 0.58 0.69
MACD -0.11 0.07
Stochastic Oscillator 37.50 91.62

Price Performance

Historical Comparison
CTRA
GMAB

About CTRA Coterra Energy Inc.

Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.

About GMAB Genmab A/S ADS

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

Share on Social Networks: